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ABSTRACT 
 
The antioxidant, antibacterial and anti-inflammatory activities, of the extract of the Narcissus broussonetii bulbs 
were studied. The report concerning those properties of this Moroccan endemic species is described for the first time. 
Nine main alkaloids compounds were identified by GC and GC-MS such as tazettine, pretazettine, homolycorine, 
lycorine, ismine, 3-epimacronine and papiramine. The extracts of N. broussonetii up to 40 mg/100g b.wt, revealed a 
significant anti-inflammatory effect in mice and showed also a significant scavenging activity at 10 mg mL
-1
. 
However, the extract showed a moderate antibacterial activity against all the microorganisms tested. 
Keywords: Amaryllidaceae, Narcissus broussonetii, Alkaloids, Pharmaceutical Activities. 
 
 
I. INTRODUCTION 
 
The Narcissus which belongs to the family of 
Amaryllidaceous is long-lived herbaceous plants. 
However the classifications of Angiosperm Phylogeny 
Group (APG) place them rather among Alliaceae, in the 
probable subfamily of Amaryllidoideae [1]. The main 
environments of Narcissus, are Morocco, Iberian 
Peninsula and nearby countries [2]. They are also 
occurring in the East to the Ukrainian Carpathian 
Mountains, in Asia Minor and in China and Japan [3]. 
 
The Narcissus are bulbous plants, with basal sheets and 
hollow stems, contracted in plate, but sometimes 
forming a rhizome, carrying of one in several yellow or 
white flowers [4].These flowers are remarkable by the 
presence of a crown stemming from the perigone, 
presented in section or in trumpet, and which contain six 
petalloids tetals, and six stamens [5,6]. The fruits are out 
of trefoil capsule containing generally numerous egg-
shaped dry seeds, and often black. The roots are fleshy 
and contractile, usually persistent during the rest period, 
and an underground bulb, which sink profoundly into 
the ground [7, 8]. 
 
Narcissus plants are mostly toxic, contain numerous 
sorts with big variability of forms and colours; their 
strong smell can give the migraine, and also loosens a 
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slightly sweetened and peppered flavor. It is since 
known century for a medicinal custom, and used in 
perfume shop [3, 7]. 
 
The Narcissus broussonetii is an endemic species of 
Morocco which quite localised in the coastal region; It is 
a hardy perennial plant which passes by a period of 
biological dormancy;  it flowered after the first rains 
(after October); his environment extends of 
Mohammedia (30 Km north of Casablanca) until the 
Oualidia and Eljadida (90 Km south of Casablanca); it 
lives in the small rocky hills with in fresh ground, and 
the rocky beds of the old rivers which thrown 
themselves into the Atlantic.  It is the flat with white 
flowers and appears in little dense population from 10 to 
60 cm in height, strong, rustic, but threatened in its 
territory; it multiplies by sowing or by division bulbs; 
the inhabitants know the plant by the strong toxicity for 
the cattle [9].  
 
The alkaloids are the main secondary metabolite of 
Narcissus plants. They have an interesting therapeutic 
effect, a great diversity of pharmacological activities and 
are also toxic [10]. 
 
More than hundreds of alkaloids are known in the 
Narcissus species. They have apparently diverse 
chemical structures, but derive all of a single precursor, 
norbelladine. These poisons are studied with interest 
view they are biologically active and they are candidates 
to make drugs [11]. 
 
Recently, de Andrade et al (2012) studied the Moroccan 
Narcissus broussonetii and mentioned that twenty three 
alkaloids were identified, including the very rare 
dinitrogenous alkaloids obliquine, plicamine, and 
secoplicamine.  Pretazettine, a potent cytotoxic alkaloid, 
was also isolated from N. broussonetii. The EtOAc 
extract of N. broussonetii showed notable antiprotozoal 
in vitro assay against Trypanosoma cruzi, with an IC50 
value of 1.77 g/ml. [12] 
 
The aim of this study is to evaluate the antioxidant, 
antibacterial and anti-inflammatory activities, of the 
ethanolic extract of the Narcissus broussonetii. The 
result of this investigation will allow us to examine the 
possibility to exploit those extracts as new 
pharmacologically acceptable drugs in the future. 
II. METHODS AND MATERIAL 
 
The mathematical editor on which along with text you 
can also write 
 
2.1. Sampling 
 
The bulbs of the Moroccan endemic Narcissus 
broussonetii were collected during November and 
December 2011 from the Atlantic region of Casablanca. 
The plant material was identified according to the flora 
of Morocco [13] and also by Pr. M. Rejdali, Agronomic 
Institute and Veterinary Hassan II, Rabat (Morocco) and 
confirmed by Pr Carles Codina, and Pr Jaume Bastida, 
Department of Natural Products, Plant Biology and Soil 
Science, Faculty of Pharmacy, Barcelona, Spain. A 
voucher specimen is deposited in the Herbarium of the 
Department of Botany and Ecology at the Agronomic 
Institute and Veterinary Hassan II, Rabat (Morocco), in 
our laboratory at the Chemistry Department at the 
Faculty of Science Ain-chock, Casablanca (Morocco) 
(herbarium n° Nb2912008) and also at the University of 
Barcelona Herbarium (BCN 58745). [21]- Jahandiz, E. 
and Maire R. 1934. Catalogue des plantes du Maroc. 
Tome III, imprimerie Minerva, Alger, Algérie 
 
2.2. Preparation of the extracts 
 
The extraction was performed following the protocol 
described by Labrana et al (12 bis). Bulbs of Narcissus 
broussonetii (3 kg) were crushed and macerated with 
EtOH for 48 h. The extract was evaporated under 
reduced pressure. The bulb crude extract (extract A) was 
(115 g). The residue dissolved in H2O and acidified with 
5% H2SO4 to pH 2-3. The acidic fraction was extracted 
with petroleum ether. After removing neutral material, 
the aqueous solution was extracted with ethyl acetate to 
provide ethyl acetate fraction (extract B). Basifying the 
aqueous solution up to pH 10-11 with 10% NH4OH and 
extracting it with n-Hexane gave hexane fraction 
(extract C).  (12 bis) J. Labra˜na, A.K. Machocho, V. 
Kricsfalusy, R. Brun, C. Codina, F. Viladomat, J. 
Bastida, Alkaloids from Narcissus angustifolius subsp. 
transcarpathicus (Amaryllidaceae), Phytochemistry 60 
(2002) 847–852. 
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Figure 1 : General diagram of the method used for obtaining 
the fractions rich in alkaloids 
 
GC–MS Analysis 
 
The EI-MS spectra were obtained on an Agilent 
6890NGC 5975 inert MSD operating in EI mode at 70 
eV (AgilentTechnologies, Santa Clara, CA, USA). A 
DB-5 MS column (30 m×0.25 mm×0.25 _m, Agilent 
Technologies) was used. The temperature program was: 
100–180 ◦C at 15 ◦C min−1, 1 min hold at 180 ◦C and 
180–300 ◦C at 5 ◦C min−1 and 40 min hold at 300 
◦C.The injector temperature was 280 ◦C. The flow rate 
of carrier gas (helium) was 0.8 ml min−1. The split ratio 
was 1:20 for the analysis of the N. broussonetii extracts. 
 
 Identification of alkaloids by GC–MS 
 
The alkaloids were identified by comparing their GC 
MS spectra and Kovats retention indices (RI) with our 
own library database. This library has been continually 
updated and reviewed with alkaloids repeatedly isolated 
by our group and identified using other spectroscopic 
techniques such as NMR, UV, CD and MS [13,14–15]. 
 
2.3. Evaluation of antioxidant activity (in vitro) 
 
The antioxidant activity of the N. broussonetii extract 
was studied in vitro using the DPPH method. The 
activity of DPPH (1, 1-Diphenyl-2-picrylhydrazyl) 
(Sigma-Aldrich, Steinheim, Germany) radical 
scavenging was investigated according to the method of 
Peiwu et al. [16]. In this method, a methanolic solution 
of DPPH (2.95 ml) was added to 50 μl sample of 
different concentrations of the extracts (10 to100 mg ml
-
1
) in disposable vial. UV spectra were recorded on a 
UV-vis spectrophotometer HP 8453. The absorbance 
was measured at 517 nm at regular intervals of 15 sec 
for 5 min. Ascorbic acid was used as a standard with 
concentration (0.1 M) [17].  
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2.4. Anti-Inflammatory activity Animals 
 
Adult’s mice of both sexes, weighing 25-28 g, were used 
in the experiments. The animals were allowed access to 
standard mouse chow and tap water. They were 
maintained in a controlled environment at 22-25 °C and 
60±5 % relative humidity with a 12 h dark/light cycle 
and acclimatized for at least one week prior to use. The 
animals were randomly assigned to different 
experimental groups. each group kept in separate cage. 
All animal procedures were performed after approval 
from the Ethics Committee of the National Research 
Centre and in accordance with the recommendations for 
the proper care and use of laboratory animals. 
 
Carrageenan-Induced Rat Paw Edema 
 
The carrageenan was used to evaluate the anti-
inflammatory properties of our ethanolic crude extract 
[18]; the mice were randomly assigned to treatment 
groups. The sterile carrageenan lambda (100 μL of a 1% 
solution in saline) was injected sub-planter into the right 
hind paw of the mice. The contralateral hind paw 
received the same volume of pure saline solution (0.9% 
NaCl) and served as a normal control (non-inflamed 
paw). Carrageenan caused visible redness and 
pronounced swelling that was well developed during 5 h 
and persisted for more than 48 h [19]. The hind footpad 
thickness was measured with a micrometer caliber [20, 
21] before and after carrageenan injection at 1, 2, 3, 4 
and 5 h. Three groups of six mice were used. The first 
group was administered saline solution (1ml) and served 
as control. The second group was tested by crude extract 
(20 and 40 mg/100 g b. wt. orally); the third group was 
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tested by indomethacin (2 mg/100 g body. wt.). The oral 
administration of the crude extract or indomethacin was 
given 1 h after carrageenan injection. 
 
The mean paw volume was measured immediately 
before carrageenan injection (Vo) and then every hour 
(Vt) for five hours post administration of the crude 
extract and control [20]. The anti-inflammatory activity 
is expressed as percentage of reduction of the edema in 
the treated mice compared to control mice. The 
percentage edema and the percentage inhibition were 
calculated as follows: 
% edema (E) = 
     
  
      
 
2.6. Antimicrobial Activity  
 
Ethanolic crude extract and fractions were tested against 
Candida albicans ATCC 28367, Fusarium solani ATCC 
36031, Staphylococcus aureus ATCC 25923, 
Pseudomonas aeruginosa ATCC 27853, Escherichia 
coli ATCC 25922 Klebsiella pneumoniae ATCC 23467 
Salmonella enteritidis ATCC 13312 and Streptococcus 
pneumoniae ATCC 49619. Identity of the bacteria 
(Origin ATCC Gene Bank) used in this study was 
confirmed by Microbial Identification System in 
Biotechnology Application and Research Center at the 
National Institute of Hygiene, Rabat, Morocco.   
 
The bacterial strains were cultured overnight at 37 ºC in 
Mueller-Hinton Agar (MHA), and the tow fungi 
Candida albicans and Fusarium solani were cultured 
overnight at 30 ºC in Sabouraud dextrose agar [22]. 
 
The antimicrobial activity was studied using the well 
diffusion method [23]. The degree of growth inhibition 
was evaluated after 48hr for bacteria and 12hr for fungi 
and compared with the growth inhibition results 
obtained from the controls (Tetracycline for bacteria and 
Nystatin for fungi).  
 
2.7. Statistical Analysis 
 
Data were expressed as Mean±SE of at least three 
independent experiments. The differences between 
control and treated groups were determined by one-way 
ANOVA followed by the least significant difference 
(LSD) [24].  
 
III. RESULT AND DISCUSSION 
 
3.1. Chemical composition of the extracts 
 
The isolated compounds led to the identification of 
seven alkaloids (Table 1) which the most important 
alkaloids are: Tazettine with an abundance of 
approximately 20.46% and 34.10% of the total mixture 
respectively in the crude extract and ethyl acetate 
fraction. In addition we observed the presence of other 
alkaloids with abundance significantly, as Homolycorine, 
Lycorine, Ismine, Prettazetine, and 3- Epimacronine.  
 
Table.1: Main alkaloids identified from Narcissus 
broussonetii 
 
Alkaloids Crude 
extract 
n-Hexane Ethyl 
acetate 
Tazettine 20.46  34.10 
Ismine 14.84  13.85 
Homolycorine 18.6 29.21  
Lycorine   29.21 
8-O 
Demetilhomolicorine 
16.84   
3-Epimacronine 2.06  2.06 
Trisferidine    
Papiramine  0.61  
Pretazettine  11.34  
Total 72.8 41.16 79.22 
 
3.2. Pharmacological Results 
 
3.2. 1. Antioxidant Activity (in vitro) 
 
The antioxidant activity of ethanol extract of 
N.broussonetii was studied in vitro using DPPH method. 
The result of the kinetics of DPPH scavenging reaction 
of ascorbic acid and N. broussonetii ethanol extract at 
different concentrations is given in figure 1. It showed a 
strong scavenging activity just after 5 second and the % 
of inhibition obtained were 82.5, 79.3, 77.9, 73.6, 72.4, 
65.2, 61.7, 62.5, 66.1 and 66.9, respectively for the 
concentrations 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 
mg mL
-1
. The values found for these samples were lower 
than those of the positive control ascorbic acid (89.8). 
The lower concentration (10 mg mL
-1
) seems to be more 
active than the higher one as shown in Figure 1.  
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Figure 2 :  The in vitro antioxidant activity of the 
ethanol extracts of N. broussonetii 
 
 
3.2. 2. Anti-Inflammatory activity 
 
Sub-planter injection of carrageenan into the mouse hind 
paw elicited an inflammation (swelling and erythma) 
and a time dependant increase in paw thickness 
compared with the pre carrageenan control value.  
 
The anti-inflammatory activity is expressed as 
percentage of reduction of the edema in the treated mice 
compared to control mice. 
 
The acute paw oedema response induced by sub-planter 
carrageenan was significantly reduced at 1, 2, 3, 4 and 5 
h by 36.7, 32.6, 30.0 29.4 and 27.3% for 20 mg of N. 
broussonetii ethanolic extract and by 34.8, 38.0, 31.5, 
32.9 and 30.4% for 40 mg of the same extract.  For 
indomethacin, the % of oedema inhibition was 34.1, 
44.6, 38.7, 48.1 and 49.2% respectively at 1, 2, 3, 4 and 
5 h (table 2).  
 
Table 2: Anti-inflammatory effect of N.broussonetii 
ethanolic extract at doses of 20 and 40 mg/100 g b. wt. 
on carrageenan-induced mice paw oedema 
 
 
 
Data are presented as Mean±SEM; Significant change 
from control values at respective time; Points are 
denoted by *p<0.05 (one way ANOVA and Duncan test) 
 
3.2.3. Antibacterial and antifungal activities 
 
The result of antibacterial activity was summarized in 
table 3. 
 
Table 3: Antimicrobial activity of ethanolic extract and 
fractions of N. broussonetii 
 
* Including the diameter of the well (4 mm);     + Mean 
value of three independent experiments 
 
The crude extracts showed significant activity against all 
Gram-positive bacteria except Salmonella enteritidis. 
The ethyl acetate fraction also showed moderate 
antibacterial activity against all bacteria whose zone of 
inhibition was ranging from (22-28 mm). The n-hexane 
fraction showed mild antibacterial activity against all 
Gram positive bacteria whose zone of inhibition was 
ranging from (19-21 mm).  
 
The ethanolic crude extracts of N. broussonetii showed 
an activity in comparison to standard. Highest Zone of 
inhibition with ethanol extract of bulbs of N. 
broussonetii was found to be 24 mm against 
Staphylococcus aurous and lowest zone of inhibition 
was found to be 10 mm against Gram negative 
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11 
Salmonella enteritidis.  The n-hexane fraction showed 
highest activity against Gram negative Staphylococcus 
aurous 25 mm and lowest zone of inhibition was found 
to be 19 mm against Gram positive Salmonella 
enteritidis. The ethyl acetate fraction showed highest 
activity against Gram positive Escherichia coli 28 mm 
and lowest zone of inhibition was found to be 22 mm 
against Gram negative Streptococcus pneumoniae. 
 
The antifungal screening was carried out against tow 
fungi Candida albicans and Fusarium solani. Ethyl 
acetate fraction was found to have a better antifungal 
activity (30-32 mm) than n-hexane (20-26 mm) and the 
crude extract (17-15mm). 
 
IV. CONCLUSION 
 
In this study, nine alkaloids from Narcissus broussonetii 
bulbs were reported. This investigation reports that the 
plant possesses antioxidant, anti-inflammatory and 
antimicrobial activities. Further studies are underway to 
reveal any additional potential of this plant as a biocide, 
and thus to determine the mechanisms of action. 
 
V. ACKNOWLEDGEMENTS 
 
This work was performed within the framework of 
project AECID A/011503/ and by the Transnational 
Cooperation Morocco-Spain. 
 
VI. REFERENCES 
[1] Angiosperm Phylogeny Group. 2003. An update of the 
Angiosperm Phylogeny Group classification for the orders and 
families of flowering plants: APG II. Bot. J. Linn. Soc., 141: 
399-436. 
[2] Fernandes, A. 1951. Sur la phylogénie des espèces du genre: 
Narcissus L. Bol. Soc. Brot. 25:148 
[3] Meerow A.W., Fay M. F., Chase M.C., Guy C.L and Li Q-B. 
2000. The New Phylogeny of the Amaryllidaceae. Herbertia., 
54: 180-203. 
[4] Lloyd D.G., Webb C.J., Dulberger R. 1990. Heterostyly in 
species of Narcissus (Amaryllidaceae), Hugonia (Linaceae) and 
other disputed cases. Plant Syst. Evol., 172: 215-227.  
[5] Meerow A.W., Fay M. F., Guy C.L., Li Q-B., Q Zaman F and 
Chase M.C. 1999. Systematics of Amaryllidaceae based on 
cladistic analysis of plastid sequence data. Am. J. Bot., 86: 13-
25.  
[6] Worley A.C., Baker A.M., Thompson J.D and Barrett S.C.H. 
2000. Floral display in Narcissus: variation in flower size and 
number at the species, population, and individual levels. Int. J. 
Plant Sci., 161: 69-79. 
[7] Meerow A. W and Snijman D.A. 2001. Phylogeny of 
Amaryllidaceae tribe Amaryllideae based on nrDNA ITS 
sequences and morphology. Am. J. Bot., 88: 2321-2330.  
[8] Dominicis RI., D'Amato G and Tucci GF. 2002. On the hybrid 
origin of Narcissus biflorus (Amaryllidaceae): analysis of C-
banding and rDNA structure. Caryologia., 55(2). 
[9] Fennane M. et Ibn Tattou M. 1998. Catalogue des plantes 
vasculaires rares, menacées ou endémiques du Maroc. Bocconea 
8:193. 
[10] Jennewein S and Croteau R. 2001. Taxol: biosynthesis, 
molecular genetics, and biotechnological applications. Appl. 
Microbiol. Biotechnol., 57: 13-19. 
[11] Ingkaninan K., Irth H., Verpoorte R. 2002. Screening of 
Amaryllidaceae for biological activities: Acetylcholineesterase 
inhibitors in Narcissus. The genus Narcissus. G.R. Hanks 
(Editor) Harwood Publishers, London., 369-379. 
[12] De Andrade J. P, Pigni N. B, Torras-Claveria L, Berkov S, 
Codina C, Viladomat F , Bastida J. 2012. Bioactive alkaloid 
extracts from Narcissus broussonetii: Mass spectral studies 
Journal of Pharmaceutical and Biomedical Analysis., 70: 13– 25 
[13] Jahandiz, E. and Maire R. 1934. Catalogue des plantes du 
Maroc. Tome III, imprimerie Minerva, Alger, Algérie (12 bis) J. 
Labra˜na, A.K. Machocho, V. Kricsfalusy, R. Brun, C. Codina, 
F. Viladomat, J. Bastida, Alkaloids from Narcissus angustifolius 
subsp. transcarpathicus (Amaryllidaceae), Phytochemistry 60 
(2002) 847–852. 
[14] Bastida J., Lavilla R and Viladomat F. 2006. Chimical and 
biological aspects of Narcissus alkaloids, The Alkaloids: J. 
Chem and Biol., 63: 87–179. 
[15] Viladomat F. Bastida J, Tribó G, Codina C, Rubiralta M. 1990. 
Alkaloids from Narcissus bicolor, Phytochemistry., 29: 1307–
1310.  
[16] Berkov S, Bastida J, Sidjimova B, Viladomat F, Codina C. 
2008. Phytochemical differentiation of Galanthus nivalis and 
Galanthus elwesii (Amaryllidaceae): a case study, Biochem. 
Syst. Ecol., 36 : 638–645.  
[17] Peiwu L., Hopia A., Jari S., Yrjnen T and Vuorela H. 1999. 
TLC method for evaluation of free radical scavenging activity 
of Rapeseed meal by video scanning technology. Proceedings of 
the 10th International Rapeseed Congress, Canberra, Australia. 
[18] Govindaragan R., Rastogi S., Vijayakumar M., Shirwaikar A., 
Rawat A.K.S., Mehrotra S and Pushpangadan P. 2003. Studies 
on the antioxidant activities of Desmodium gangeticum. Biol. 
Pharm. Bull., 26: 1424-1427. 
[19] Winter C.A., Risley E.A and Nuss G.W. 1962. Carrageenan 
induced edema in hind paw of the rat as an assay for anti-
inflammatory drug. Proc. Soc. Exp. Biol. Med., 111: 544-547. 
[20] Vinegar R., Truax J.F and Selph J.L. 1976. Quantitative 
comparison of the analgesic and anti-inflammatory activities of 
aspirin, phenacetin and acetaminophen in rodents. Eur. J. 
Pharmacol., 37: 23-30. 
[21] Meng L., Mohan R., Kwok B.H.B., Elofsson M., Sin N and 
Crews C.M. 1999. Epoxomicin, a potent and selective 
proteasome inhibitor, exhibits in vivo anti-inflammatory 
activity. Proc. Natl. Acad. Sci., 96: 10403-10408.  
[22] Obukowics M.G., Welsch D.J., Salsgiver W.J., Martin-Berger 
C.L and Chinn K.S. 2005. Novel, selective 6 or 5 fatty acid 
desaturase inhibitors as anti-inflammatory agents in mice. J. 
Pharmacol. Exp. Ther., 287: 157-166 
[23] Chabbert Y.A., Daguet G. L. 1985. Techniques en bactériologie 
: antibiotiques en bactériologie médicale. Editeur: Flammarion, 
Médecine & Sciences, Sérologie bactérienne.  
[24] Vanden Berghe D.A., Vlietinck A.J., 1991. Screening methods 
for antibacterial and antiviral agents from higher plants. In: 
Hostettmann K. Ed., Methods in plant biochemistry, vol. 6. 
London, UK, Academic Press, p. 47-69. 
[25] Armitage P. 1971. Statistical Methods in Medical. Black Well 
Scientific Publications, London.F. Damerau, A technique for 
computer detection and correction of spelling errors. 
Communications of the ACM, 1964, Vol. 7, Issue 3, pp. 659-
664.  
